Shows & Panels
- The 2014 Big Picture on Cyber Security
- AFCEA Answers
- Ask the CIO
- Building the Hybrid Cloud
- Connected Government: How to Build and Procure Network Services for the Future
- Continuing Diagnostics and Mitigation: Discussion of Progress and Next Steps
- Federal Executive Forum
- Federal Tech Talk
- The Future of Government Data Centers
- The Future of IT: How CIOs Can Enable the Service-Oriented Enterprise
- The Intersection: Where Technology Meets Transformation
- Maximizing ROI Through Data Center Consolidation
- Mitigating Insider Threats in Virtual & Cloud Environments
- Modern Mission Critical Series
- Moving to the Cloud. What's the best approach for me
- Navigating Tough Choices in Government Cloud Computing
- The New Generation of Database
- Satellite Communications: Acquiring SATCOM in Tight Times
- Targeting Advanced Threats: Proven Methods from Detection through Remediation
- Transformative Technology: Desktop Virtualization in Government
- The Truth About IT Opex and Software Defined Networking
- Value of Health IT
- Air Traffic Management Transformation Report
- Cloud First Report
- General Dynamics IT Enterprise Center
- Gov Cloud Minute
- Government in Technology Series
- Homeland Security Cybersecurity Market Report
- National Cybersecurity Awareness Month
- Technology Insights
- The Cyber Security Report
- The Next Generation Cyber Security Experts
Shows & Panels
Spain court orders German thalidomide firm to pay
Wednesday - 11/20/2013, 12:41pm EST
MADRID (AP) -- A Spanish court on Wednesday ordered a German pharmaceutical company to pay compensation to 22 Spaniards born with disabilities after their mothers used the drug thalidomide during pregnancy decades ago.
Madrid's provincial court ordered the Gruenenthal Group in Spain to pay 20,000 euros ($26,300) for each percentage point of disability of victims recognized by Spain's Health Ministry.
The total compensation bill was not immediately made known but it was much lower than the 204 million euros sought by The Spanish Association of Thalidomide Victims, which brought the case for some 200 alleged victims.
Thalidomide was a sedative prescribed between 1950 and 1960 for morning sickness. Thousands of babies whose mothers used it were born worldwide with abnormally short limbs and in some cases without arms, legs or hips.
Gruenenthal said in a statement that it was disappointed with the outcome and "will now assess the judgment in great detail and then decide on the appropriate course of action."
The company said it "cares about those affected by thalidomide" but said its conduct during the era that thalidomide was prescribed was consistent with "prevailing standards for the development and testing in the pharmaceutical industry at that time."
Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.